⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Orlistat
اورلیستات
🍽️ Alimentary Tract And MetabolismLipase inhibitor (anti-obesity)
🤰 Pregnancy:Contraindicated🤱 Breastfeeding:Use with caution👶 Children:Use with caution👴 Older adults:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA020766ATC A08AB01
Market / country: 🇺🇸 USA
Xenical (US)
🧮 Dose calculator
Obesity · Regimen source: FDA Xenical · 2
- • During or up to 1 h after the meal; skip if the meal is missed or fat-free. Reduced-calorie diet with about 30% fat. Multivitamin with fat-soluble vitamins 2 h apart. FDA Xenical · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy; chronic malabsorption; cholestasis; hypersensitivity. FDA Xenical · 4
Formulations
- 120 mg capsule — capsule 🇺🇸 USA FDA Xenical · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Xenical · 4
“XENICAL is contraindicated in: Pregnancy [see Use in Specific Populations (8.1) ] Patients with chronic malabsorption syndrome Patients with cholestasis Patients with known hypersensitivity to XENICAL or to any component of this product Pregnancy ( 4 , 8.1 ) Chronic malabsorption syndrome ( 4 ) Cholestasis ( 4 ) Known …”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Xenical · 8.3
“Caution should be exercised when XENICAL is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Xenical · 8.4
“Safety and effectiveness in pediatric patients below the age of 12 have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Xenical · 8.5
“Clinical studies of XENICAL did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently from younger patients [see Clinical Studies (14) ] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020766
- DailyMed (FDA label)FDA Xenical
- MedlinePlus (NIH)Orlistat
- WHO ATC/DDDA08AB01
- Darooyab (Iran)Orlistat
🇮🇷 Registered in Iran Darooyab · G-4071/Orlistat
Dosage forms with Iranian generic codes, per Darooyab.
- 02283 · ORLISTAT 120MG CAP · کپسول اورلیستات ۱۲۰ میلیگرم
- 11883 · ORLISTAT 60MG CAP · کپسول اورلیستات ۶۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Xenical · 3FDA Xenical · 2FDA Xenical · 4FDA Xenical · SPL approval / marketing categoryFDA Xenical · 8.3FDA Xenical · 8.4FDA Xenical · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4071/Orlistat
- Clinical review⚠ Unverified